TABLE 5.
Molecular Alteration | Malignant Histology, No. | Benign Histology, No. | Risk of Malignancy, % | OR | P |
---|---|---|---|---|---|
NRAS alone | 3 | 17 | 15 | 0.166 | .0322 |
NRAS with others | 9 | 8 | 53 | ||
HRAS alone | 3 | 8 | 27 | 0.88 | .63 |
HRAS with others | 3 | 7 | 30 | ||
KRAS alone | 1 | 6 | 14 | 0.44 | .5 |
KRAS with others | 2 | 5 | 29 | ||
RAS mutation (overall) | 21 | 51 | 29 | ||
RAS mutation (alone) | 7 | 31 | 18 | 0.33 | .031 |
RAS with others | 14 | 20 | 41 |
Abbreviation: OR, odds ratio.